Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-23-003187
Accepted
2023-11-06 00:15:25
Documents
1
Effectiveness Date
2023-11-03
Registration Form
F-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 596
  Complete submission text file 9999999995-23-003187.txt   1855
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-275002 | Film No.: 231377947
SIC: 2834 Pharmaceutical Preparations